Bone Anchored Hearing Devices
Bone anchored hearing devices are used to treat conductive hearing loss and single-sided deafness in patients who do not benefit from traditional hearing aids. These devices work through bone conduction, transmitting sound vibrations directly to the inner ear while bypassing the outer and middle ear.
Bone Anchored Hearing Devices
Bone anchored hearing devices (BAHD) are designed for specific types of hearing loss, including single-sided deafness and conductive hearing loss. These conditions may result from factors such as viral infections, Meniere’s disease, trauma, measles, sudden hearing loss, or an acoustic neuroma. Conductive hearing loss can also be present at birth or develop later due to malformation of the outer or middle ear or chronic ear infections.
How It Works
Unlike traditional hearing aids that rely on air conduction—where sound travels through the ear canal and middle ear—a bone anchored hearing device uses bone conduction. This means it sends gentle vibrations through the skull directly to the inner ear (cochlea), allowing sound to bypass damaged parts of the ear.
Because this system works differently from standard hearing aids, it can be an excellent option for patients who cannot benefit from traditional devices. Many insurance plans cover bone anchored hearing devices.
Osia® Implant System
The Osia system is an osseointegrated system designed to treat conductive hearing loss, mixed hearing loss, and single-sided deafness. The implant is placed under the skin and bypasses damaged areas of the outer and middle ear to send sound directly to the inner ear. It connects to the BI300 titanium implant, which is designed to integrate quickly and securely with the bone. An external sound processor connects magnetically to the implant. The external sound processor detects sound and converts it into digital signals that are sent to the internal implant.
Who It’s For
The Osia system is intended for individuals with suitable conductive hearing loss, mixed hearing loss, and single-sided deafness. It is approved for adults and children (ages 5 and up) in the U.S. and Canada.